Xujie Sun

643 total citations · 1 hit paper
34 papers, 377 citations indexed

About

Xujie Sun is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xujie Sun has authored 34 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xujie Sun's work include Lung Cancer Research Studies (10 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Xujie Sun is often cited by papers focused on Lung Cancer Research Studies (10 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Xujie Sun collaborates with scholars based in China, United States and Norway. Xujie Sun's co-authors include Zujun Chen, Shuang Rong, Yaping Li, Jianming Ying, Yibo Zhang, Meng Zhou, Xiaoting Shan, Lin Yang, Zicheng Zhang and Li Liu and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Xujie Sun

32 papers receiving 374 citations

Hit Papers

Injectable supramolecular hydrogel co-loading abemaciclib... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
    2025 16 citations Ying Cai, Lingli Zhou et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xujie Sun China 12 136 92 88 65 53 34 377
Kai Guo China 12 157 1.2× 87 0.9× 73 0.8× 96 1.5× 58 1.1× 32 347
Yujie Tan China 10 81 0.6× 62 0.7× 128 1.5× 66 1.0× 43 0.8× 38 335
Zebin Chen China 12 118 0.9× 83 0.9× 99 1.1× 181 2.8× 59 1.1× 28 485
Michael Li United States 12 168 1.2× 56 0.6× 77 0.9× 29 0.4× 45 0.8× 32 388
Jingjuan Zhu China 12 204 1.5× 194 2.1× 147 1.7× 53 0.8× 54 1.0× 28 483
Xihui Ying China 9 102 0.8× 95 1.0× 71 0.8× 99 1.5× 58 1.1× 18 397
Yudong Qiu China 11 70 0.5× 54 0.6× 79 0.9× 53 0.8× 125 2.4× 34 345
Wenjuan Wang China 11 77 0.6× 33 0.4× 93 1.1× 52 0.8× 46 0.9× 30 395
Junli Shi China 11 67 0.5× 71 0.8× 67 0.8× 105 1.6× 70 1.3× 17 336

Countries citing papers authored by Xujie Sun

Since Specialization
Citations

This map shows the geographic impact of Xujie Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xujie Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xujie Sun more than expected).

Fields of papers citing papers by Xujie Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xujie Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xujie Sun. The network helps show where Xujie Sun may publish in the future.

Co-authorship network of co-authors of Xujie Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xujie Sun. A scholar is included among the top collaborators of Xujie Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xujie Sun. Xujie Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zicheng, Siqi Bao, Xujie Sun, et al.. (2025). Integrative multi-omics profiling deciphers tumor microenvironment heterogeneity and immunotherapy vulnerabilities in lung neuroendocrine carcinomas. Journal of Advanced Research. 81. 797–808. 1 indexed citations
2.
Shan, Xiaoting, Ying Cai, Xujie Sun, et al.. (2025). Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy. Advanced Healthcare Materials. 14(7). e2404261–e2404261. 3 indexed citations
3.
Sun, Xujie, et al.. (2025). Eugenol alleviates renal ischemia-reperfusion injury induced-endoplasmic reticulum stress via activating Sestrin2. Clinics. 80. 100627–100627. 1 indexed citations
4.
Cai, Ying, Lingli Zhou, Lei Zhao, et al.. (2025). Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer. Nature Communications. 16(1). 687–687. 16 indexed citations breakdown →
5.
Wang, Haiyang, Yufei Zhang, Xujie Sun, et al.. (2025). Thermodynamic analysis of a near-isothermal compressed air energy storage system based on internal combustion engine assistance. Applied Thermal Engineering. 275. 126815–126815. 1 indexed citations
6.
7.
8.
Sun, Xujie, Li Liu, Jingbo Liu, et al.. (2024). Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic Cancer. 15(7). 519–528. 4 indexed citations
9.
Wang, Mengmeng, Xujie Sun, Yutong Wang, et al.. (2024). A prodrug nanodevice co-delivering docetaxel and ROR1 siRNA for enhanced triple negative breast cancer therapy. Acta Biomaterialia. 193. 498–513. 2 indexed citations
10.
11.
Shan, Xiaoting, Ying Cai, Lingli Zhou, et al.. (2024). Rational strategies for improving the efficiency of design and discovery of nanomedicines. Nature Communications. 15(1). 9990–9990. 24 indexed citations
12.
Liu, Yunsong, Yi Wang, Xin Wang, et al.. (2024). MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study. Cancer Imaging. 24(1). 16–16. 11 indexed citations
13.
Zhang, Yibo, Yanli Zhu, Li Liu, et al.. (2024). Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer. npj Digital Medicine. 7(1). 15–15. 45 indexed citations
14.
Liu, Yiran, Ning Yang, Tian Zhang, et al.. (2024). Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer. Pharmaceutics. 16(4). 570–570. 1 indexed citations
15.
Yu, Haijun, Ting Wu, Xujie Sun, et al.. (2023). Breaking Tumor Immunosuppressive Network by Regulating Multiple Nodes with Triadic Drug Delivery Nanoparticles. ACS Nano. 17(18). 17826–17844. 18 indexed citations
16.
Liu, Li, Zongyi Chen, Guixiang Ma, et al.. (2023). Explainable survival analysis with uncertainty using convolution-involved vision transformer. Computerized Medical Imaging and Graphics. 110. 102302–102302. 6 indexed citations
17.
Cai, Ying, Xiaoting Shan, Lingli Zhou, et al.. (2023). Inhibiting Endothelial Cell‐Mediated T Lymphocyte Apoptosis with Integrin‐Targeting Peptide‐Drug Conjugate Filaments for Chemoimmunotherapy of Triple‐Negative Breast Cancer. Advanced Materials. 36(3). e2306676–e2306676. 12 indexed citations
18.
Sun, Xujie, Jinyao Zhang, Li Liu, et al.. (2022). Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC). Translational Oncology. 25. 101538–101538. 3 indexed citations
19.
Sun, Xujie, Liying Dong, Tao Chen, et al.. (2019). Pooled analysis of efficacy and safety of ureteral stent removal using an extraction string. Medicine. 98(37). e17169–e17169. 5 indexed citations
20.
Cui, Yuanshan, et al.. (2017). Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis. International Neurourology Journal. 21(1). 53–61. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Guo Breakdown of academic impact, for papers by Yujie Tan Breakdown of academic impact, for papers by Zebin Chen Breakdown of academic impact, for papers by Michael Li Breakdown of academic impact, for papers by Jingjuan Zhu Breakdown of academic impact, for papers by Xihui Ying Breakdown of academic impact, for papers by Yudong Qiu Breakdown of academic impact, for papers by Wenjuan Wang Breakdown of academic impact, for papers by Junli Shi
Rankless by CCL
2026